Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019



Giuliana  Vallanti

Giuliana Vallanti

Development & Quality Control Director, Qualified Person, MolMed

Giuliana Vallanti is Development and Quality Control Director and Qualified Person in MolMed. She joined MolMed in 2005 and worked with growing responsibilities in Development  and Quality Control units, contributing to the development of processes and assays in cell and  gene therapy field. She has main experiences in the development and industrialization of T- and haematopietic cells  transduction processes  with lentiviral and retroviral vectors. She worked on the development of GMP processes for large scale vectors production and purification. She holds a degree in Biology  from Università degli Studi - Urbino and a Ph.D. in biochemical and pharmacological methods with a study on  Lentiviral Vector for gene therapy anti HIV-1.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd